Showing results (201-210 of 236) with videos related to
Sort By:
Pageof 24
RSC Advances|October 9, 2023
Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compoundsTanachote Ruengsatra, Arthitaya Meeprasert, Eakkaphon Rattanangkool, et al.The Journal of Antimicrobial Chemotherapy|February 19, 2026
Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyWin Min Han, Tanakorn Apornpong, Natthaya Chuaypen, et al.HIV Medicine|May 11, 2023
Metabolic-Associated Fatty Liver Disease (MAFLD) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with HIV in a Thai cohortWin Min Han, Tanakorn Apornpong, Pairoj Chattranukulchai, et al.BMC Gastroenterology|March 7, 2020
Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort studyPhunchai Charatcharoenwitthaya, Virasak Wongpaitoon, Piyawat Komolmit, et al.Liver Cancer|February 2, 2026
Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi PanelAmit G Singal, Hidenori Toyoda, Tawesak Tanwandee, et al.Journal of Viral Hepatitis|September 1, 2021
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety studyRobin Erken, Patrice Andre, Elise Roy, et al.Journal of Gastroenterology and Hepatology|April 16, 2014
Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levelsAnchalee Avihingsanon, Salyavit Jitmitraparp, Pisit Tangkijvanich, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Incident Liver Cirrhosis, Associated Factors, and Cardiovascular Disease Risks Among People Living With HIV: A Longitudinal StudyWin Min Han, Thornthun Ueaphongsukkit, Pairoj Chattranukulchai, et al.Plos One|August 24, 2018
Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policyRujipat Wasitthankasem, Preeyaporn Vichaiwattana, Nipaporn Siripon, et al.Plos One|April 25, 2018
Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based studyRujipat Wasitthankasem, Preeyaporn Vichaiwattana, Nipaporn Siripon, et al.Pageof 24